UNSPSC 85523112: Supplement right hand vein with autologous tissue substitute, open approach

This classification denotes the group of activities that yields a surgical intervention or procedure to supplement right hand vein with autologous tissue substitute, open approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 05UG07Z

UNSPSC 85523112, Supplement right hand vein with autologous tissue substitute, open approach, is a Commodity code that shows minimal alignment with recent state and local procurement activity. The code's clinical specificity—a surgical procedure for vascular supplementation—does not match the scope of work actually being solicited by state and local issuers. Recent opportunities tagged to this code span occupational medical surveillance, disability medical evaluations, pharmacy benefit management, health professional staffing, surgical benefit carve-out programs, and youth detention healthcare services. These represent procurement for administrative medical services, staffing arrangements, and healthcare program management rather than surgical procedures or tissue-based medical devices. State and local bodies issuing under this code include county health systems, departments of transportation, retirement offices, county commissioners, and juvenile probation departments. The issuing-body mix reflects broad healthcare and employee-benefit purchasing across administrative, occupational, and custodial health programs rather than procedural surgery.

Recent opportunities with clear activity include the Washington State Department of Transportation's occupational medical surveillance RFP (response due October 9, 2026), the City of Phoenix Retirement Office's independent medical evaluation services RFP for disability determinations (response due October 16, 2026), and the City of Long Beach's surgical and medical procedure carve-out benefit program RFP (response due October 7, 2026). Activity appears concentrated in California, Washington, Arizona, and Florida, with no pattern suggesting this code captures meaningful procurement volume for the clinical procedure its name describes. The code assignment appears to be a classification mismatch rather than a reliable indicator of related buying activity.